OWLT trades 238.4% below Wall Street's consensus target of $20.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes OWLT achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 7, 2026, Owlet, Inc. (OWLT) has a Wall Street consensus price target of $20.00, based on estimates from 5 covering analysts. With the stock currently trading at $5.91, this represents a potential upside of +238.4%. The company has a market capitalization of $21M.
Analyst price targets range from a low of $20.00 to a high of $20.00, representing a 0% spread in expectations. The median target of $20.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, OWLT trades at a trailing P/E of -2.6x. Analysts expect EPS to grow +96.8% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
SNBRSleep Number Corporation | $3M | $0.13 | $10.00 | +7774.0% | Hold | — | 11 |
IRMDIRadimed Corporation | $1.3B | $102.30 | $120.00 | +17.3% | Buy | 49.3x | 2 |
MASIMasimo Corporation | $9.4B | $179.95 | $180.00 | +0.0% | Buy | 32.7x | 23 |
INVAInnoviva, Inc. | $1.6B | $21.82 | $37.00 | +69.6% | Buy | 6.1x | 10 |
LMATLeMaitre Vascular, Inc. | $2.4B | $103.72 | $127.50 | +22.9% | Buy | 34.6x | 20 |
NVCRNovoCure Limited | $2.0B | $17.32 | $33.00 | +90.5% | Buy | — | 15 |
GKOSGlaukos Corporation | $8.7B | $148.70 | $153.33 | +3.1% | Buy | — | 24 |
AMZNAmazon.com, Inc. | $2.6T | $244.16 | $307.77 | +26.1% | Buy | 27.7x | 94 |
AAPLApple Inc. | $4.6T | $312.66 | $327.00 | +4.6% | Buy | 35.7x | 111 |
QCOMQUALCOMM Incorporated | $196.5B | $186.48 | $218.50 | +17.2% | Hold | 17.3x | 69 |
Quick answers to the most common questions about buying OWLT stock.
The consensus Wall Street price target for OWLT is $20, representing 238.4% upside from the current price of $5.91. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
OWLT has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $20 implies 238.4% upside from current levels.
OWLT's current price is $5.91 with a consensus target of $20 (238.4% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $20 for OWLT, while the most conservative target is $20. The consensus of $20 represents the median expectation. These targets typically reflect 12-month expectations.
OWLT is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month OWLT stock forecast based on 5 Wall Street analysts shows a consensus price target of $20, with estimates ranging from $20 (bear case) to $20 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on OWLT, with a "Buy" consensus rating and $20 price target (238.4% upside). 3 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
OWLT analyst price targets range from $20 to $20, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $20 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.